For the quarter ending 2026-03-31, RZLT has $125,459K in assets. $8,625K in debts. $11,236K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 11,236 | 11,944 | 9,098 | 94,107 |
| Investments in marketable debt securities | 109,032 | 120,994 | 143,096 | 73,751 |
| Prepaid expenses and other | 1,781 | 2,168 | 2,514 | 3,287 |
| Total current assets | 122,049 | 135,106 | 154,708 | 171,145 |
| Deposits and other | 2,443 | 2,402 | 2,684 | 2,925 |
| Right-of-use assets | 918 | 1,064 | 1,208 | 1,348 |
| Property and equipment, net | 49 | 57 | 64 | 72 |
| Total assets | 125,459 | 138,629 | 158,664 | 175,490 |
| Accounts payable | 3,195 | 3,783 | 3,259 | 5,809 |
| Accrued clinical and other | 2,802 | 3,548 | 2,982 | 3,202 |
| Compensation and benefits | 1,034 | 1,532 | 3,318 | 2,269 |
| Current portion of operating lease liabilities | 673 | 666 | 650 | 632 |
| Total current liabilities | 7,704 | 9,529 | 10,209 | 11,912 |
| Embedded derivative liability | 483 | 483 | 483 | 468 |
| Operating lease liabilities, net of current portion | 438 | 619 | 804 | 983 |
| Total liabilities | 8,625 | 10,631 | 11,496 | 13,363 |
| Common stock, 0.001 par value 165,000,000 shares authorized issued and outstanding 96,292,331 and 86,995,985 shares as of march 31, 2026 and june 30, 2025, respectively | 96 | 96 | 91 | 87 |
| Additional paid-in capital | 577,804 | 572,635 | 569,034 | 565,903 |
| Accumulated other comprehensive loss | -115 | 47 | 49 | -7 |
| Accumulated deficit | -460,951 | -444,780 | -422,006 | -403,856 |
| Total shareholders' equity | 116,834 | 127,998 | 147,168 | 162,127 |
| Total liabilities and shareholders' equity | 125,459 | 138,629 | 158,664 | 175,490 |
Rezolute, Inc. (RZLT)
Rezolute, Inc. (RZLT)